These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7807486

  • 1. Lipoprotein alterations from a triphasic oral contraceptive containing ethinyl estradiol and gestodene. A 12-month trial.
    Moutos DM, Zacur HA, Bachorik PS, Wallach EE.
    J Reprod Med; 1994 Sep; 39(9):720-4. PubMed ID: 7807486
    [Abstract] [Full Text] [Related]

  • 2. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Sep; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 3. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Sep; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 4. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A, Sobbrio GA, D'Arrigo F, Barillari M, Curasì MP, Egitto M, Trimarchi F, Granese D, Pullè C.
    Acta Eur Fertil; 1990 Sep; 21(3):143-6. PubMed ID: 2149913
    [Abstract] [Full Text] [Related]

  • 5. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
    Wiegratz I, Jung-Hoffmann C, Gross W, Kuhl H.
    Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262
    [Abstract] [Full Text] [Related]

  • 6. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
    Lepot MR, Gaspard UJ.
    Int J Fertil; 1987 Aug; 32 Suppl():15-20. PubMed ID: 2906343
    [Abstract] [Full Text] [Related]

  • 7. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.
    Gaspard U, Endrikat J, Desager JP, Buicu C, Gerlinger C, Heithecker R.
    Contraception; 2004 Apr; 69(4):271-8. PubMed ID: 15033400
    [Abstract] [Full Text] [Related]

  • 8. Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile.
    Creasy GW, Fisher AC, Hall N, Shangold GA.
    J Reprod Med; 2003 Mar; 48(3):179-86. PubMed ID: 12698776
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
    Bertolini S, Elicio N, Cordera R, Gapitanio GL, Montagna G, Croce S, Saturnino M, Balestreri R, De Cecco L.
    Acta Obstet Gynecol Scand; 1987 Mar; 66(4):327-32. PubMed ID: 2962417
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of lipid profile in adolescents during long-term use of combined oral hormonal contraceptives.
    Guazzelli CA, Lindsey PC, de Araújo FF, Barbieri M, Petta CA, Aldrighi JM.
    Contraception; 2005 Feb; 71(2):118-21. PubMed ID: 15707561
    [Abstract] [Full Text] [Related]

  • 16. A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.
    März W, Gross W, Gahn G, Romberg G, Taubert HD, Kuhl H.
    Am J Obstet Gynecol; 1985 Oct 01; 153(3):287-93. PubMed ID: 2931988
    [Abstract] [Full Text] [Related]

  • 17. Lipid profile in women over 35 years old using triphasic combined oral contraceptives.
    Aldrighi JM, Petta CA, Bahamondes L, Caetano ME, Martinez TR, De Lima GR.
    Contraception; 2004 May 01; 69(5):395-9. PubMed ID: 15105062
    [Abstract] [Full Text] [Related]

  • 18. [Inhibition of ovarian function using a triphasic combination with gestodene].
    Rozenbaum H.
    Rev Fr Gynecol Obstet; 1988 Jun 15; 83(6):449-52. PubMed ID: 3406638
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The clinical and biochemical effects of two combination oral contraceptive agents.
    Sapire KE, Berger GM, Maritz JS.
    S Afr Med J; 1991 Apr 06; 79(7):376-9. PubMed ID: 1826569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.